Aldurazyme Evropska unija - slovenščina - EMA (European Medicines Agency)

aldurazyme

sanofi b.v. - laronidaza - mucopolisaharidoza i - drugi zdravljene bolezni prebavil in presnove izdelki, - aldurazyme je označen za dolgoročno encim nadomestno zdravljenje pri bolnikih s potrjeno diagnozo mucopolysaccharidosis i (mps i; alfa-l-iduronidase pomanjkljivost) za zdravljenje nonneurological manifestacije bolezni.

Enhertu Evropska unija - slovenščina - EMA (European Medicines Agency)

enhertu

daiichi sankyo europe gmbh - trastuzumab deruxtecan - neoplazme dojke - antineoplastična sredstva - breast cancerher2-positive breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-positive breast cancer who have received one or more prior anti-her2-based regimens. her2-low breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy (see section 4. non-small cell lung cancer (nsclc)enhertu as monotherapy is indicated for the treatment of adult patients with advanced nsclc whose tumours have an activating her2 (erbb2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy. gastric cancerenhertu as monotherapy is indicated for the treatment of adult patients with advanced her2-positive gastric or gastroesophageal junction (gej) adenocarcinoma who have received a prior trastuzumab-based regimen.

Ribas 2,5 mg filmsko obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

ribas 2,5 mg filmsko obložene tablete

rivaroksaban - filmsko obložena tableta - rivaroksaban 2,5 mg / 1 tableta - rivaroksaban